What’s good for the goose… –

June 22, 2019 – The FDA acknowledged that it’s not clear how Vyleesi acts in the brain to affect sexual desire or distress. It advises women to use no more than one dose in 24 hours or eight a month. And there’s disagreement about whether drugs are the right approach — low sexual desire can be a result of numerous psychological, physiological or external factors, including stress — and how widespread the condition really is.

One study estimated that as many as one out of 10 women may have low sexual desire, and the FDA several years ago convened a meeting to better understand the impact of female sexual dysfunction. Critics have pointed out that nearly all of the doctors on the recent panel that defined HSDD were consultants or advisory board members for Sprout Pharmaceuticals, the drugmaker that introduced the world to the first women’s libido drug, Addyi, also known as flibanserin, in 2015.

Full Story @ ScienceAlert.com